HarveyIPassMD

Adult General Thoracic Surgery, Thoracic Surgical Oncology, Cardiovascular Surgery

Professor of Surgery, NYU School of Medicine; Stephen E. Banner Professor of Thoracic Oncology; Vice-Chair Research, Department of Cardiothoracic Surgery; Division Chief, General Thoracic Surgery

Join to view full profile

Dr. Pass is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pass' full profile

Already have an account?

Office
530 First avenue, Cardiothoracic, 9V
7th Floor
New York, NY 10016
Phone+1 914-330-4707

Fax+1 212-263-2042

Summary

Harvey Pass, MD, is a renowned Thoracic Surgeon based in New York with subspecialties in Adult General Thoracic Surgery, Thoracic Surgical Oncology, and Cardiovascular Surgery. He completed his medical education and residencies at institutions including Duke University Hospital and the Medical University of South Carolina. Dr. Pass currently holds multiple positions at NYU Langone Health and has extensive experience in various medical procedures, including transesophageal echocardiography and treatment of conditions such as squamous cell carcinoma of the esophagus. He's active in conducting clinical trials and has contributed to a number of medical publications. Over the years, Dr. Pass has continually received prestigious honors including Top Doctors: New York Metro Area and America's Top Doctors for Cancer by Castle Connolly.

Education & Training

Medical University of South CarolinaFellowship, Thoracic Surgery, 1980 - 1982
University of Mississippi Medical CenterResidency, Surgery, 1977 - 1980
Duke University HospitalResidency, Surgery, 1973 - 1975
Duke University School of MedicineClass of 1973

Certifications & Licensure

NY State Medical License 2005 - 2026
MI State Medical License 1996 - 2006
SC State Medical License 1980 - 1983

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2007-2016
New York Magazine: Top Doctors Castle Connolly, 2006-2016
America's Top Doctors for Cancer Castle Connolly, 2005-2016
America's Top Doctors Castle Connolly, 2002-2016
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Start of enrollment: 2007 Oct 12
Active, not recruiting
Phase 3
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery Start of enrollment: 2007 Dec 01
Completed
Phase 2
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma Start of enrollment: 2008 Mar 01
Unknown status
Phase 2
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma Start of enrollment: 2011 Jun 01
Completed
Early Diagnosis of Pulmonary Nodules Start of enrollment: 2012 Oct 01
Completed
Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2014 Jul 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

A Perspective on the MARS2 Trial.
Eric Lim, Isabelle Opitz, Gavitt Woodard, Raphael Bueno, Marc de Perrot
Journal of Thoracic Oncology. 2025-01-08
Going to MARS may shorten our patient's survival.
R Taylor Ripley, Prasad S Adusumilli, Adam J Bograd, Servet Bölükbas, Raphael Bueno
The Journal of Thoracic and Cardiovascular Surgery. 2024-12-13
1 citations
Lung allograft dysbiosis associates with immune response and primary graft dysfunction.
Nathaniel C Nelson, Kendrew K Wong, Ian J Mahoney, Tahir Malik, Darya Rudym
The Journal of Heart and Lung Transplantation. 2024-11-17

Journal Articles

Epigenetically Regulated PAX6 Drives Cancer Cells Toward a Stem-like State via GLI-SOX2 Signaling Axis in Lung Adenocarcinoma
William N Rom, Harvey I Pass, Zahra Maleki, Nature
A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT
Anil Vachani, William N Rom, Gerard Criner, Harvey Pass, Clinical Cancer Research
Airway Microbiota Is Associated with up-Regulation of the PI3K Pathway in Lung Cancer
Benjamin G Wu, Harvey Pass, William N Rom, Daniel H Sterman, Vivek Murthy, Martin J Blaser, Michael D Weiden, Leopoldo N Segal, ATS Journals

Authored Content

Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1–4 Branching, β1–6 Branching, and α2–6 Sialylation in CancerNovember 2017

Press Mentions

Life-Saving New Approaches for Mesothelioma Cancer RecommendedMay 4th, 2022
The Best Biomarkers for Mesothelioma Diagnosis, Prognosis, & MonitoringJuly 27th, 2020
‘It's a Big Deal’: Surgeon Group Studying Thoracic Disease Is GrowingJanuary 9th, 2020
Join now to see all